Silvia Cerolini ProQR, Code C (Consultant/Contractor), Sanofi, Code E (Employment);
Jean Bennett Frontera, Akouos, Spark Therapeutics, Sparing Vision, Regenx Bio, Code C (Consultant/Contractor), Gyroscope, Accugen, Code F (Financial Support), Opus Genetics, Code O (Owner), U Penn, Code P (Patent);
Bart Leroy 4DMT, AAVantgardeBio, Akouos, Asthena Therapeutics, Bayer, Biogen, GenSight Biologics, Iveric Bio, Janssen, Novartis, Opus Genetics, Oxurion, ProQr Therapeutics, RegenxBio, Santen, Spark Therapeutics, Transine Therapeutics, Vedere Bio, ViGeneron, Code C (Consultant/Contractor), Biogen, GenSight Biologics, Janssen, MeiraGTX, Novartis, ProQR Therapeutics, Code F (Financial Support), GenSight Biologics, Iveric Bio, Novartis, ProQR Therapeutics, Spark Therapeutics , Code R (Recipient);
Tomas Aleman U Penn, Code P (Patent);
Avril Daly None;
Todd Durham None;
Courtney Coates None;
Mathew Pletcher Ray Therapeutics, Code C (Consultant/Contractor), Kisbee Therapeutics, Code E (Employment);
Sue Lacey Adverum, Nanoscope, Code C (Consultant/Contractor), Adverum, Code I (Personal Financial Interest)